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ABSTRACT: 
 
Stem cells are known to have the ability to renew themselves and differentiate into a diverse range of 
specialized cell types. Currently, the differentiation potential of human peripheral blood mononucleated 
cells in suspension as stem cells is not well-understood. The aim of this study was to investigate the 
differentiation potential of suspension mononucleated cells from human peripheral blood to 
differentiate. The osteoblast and osteoclast differentiation potential of suspension peripheral blood 
mononucleated cells were examined by molecular, biochemical and cell morphology analyses. The 
expression of osteoblast marker (osteonectin, SPARC) and osteoclast marker (tartrate resistant acid 
phosphatase, TRAP) as well as high alkaline phosphate (ALP) and TRAP enzyme activity were observed at 
days 14 and 10 of osteoblast and osteoclast differentiation, respectively. Morphology analyses showed 
that mononucleated cells successfully differentiated into osteoblasts and osteoclasts. The existence of 
stem cells in mononucleated cells was evaluated by the expression of a stem cell factor (KIT) and a 
haematopoietic stem cell marker (signalling lymphocytic activation molecule family member 1, SLAMF1). 
This study has shown that these suspension mononucleated cells possess differentiation potential 
through in vitro study. Human peripheral blood suspension mononucleated cells that have multi-lineage 
differentiation potential may provide a new source of stem cells that may be used for bone regeneration 
and tissue engineering applications. 
